COVID-19 vaccination: effective utilization of low dead space (LDS) syringes

COVID-19 vaccination: effective utilization of low dead space (LDS) syringes

•In maximally utilizing COVID vaccine, syringes with low dead space (LDS) are required.•We employed insulin LDS syringes, when no suitable syringes were procured.•US assessment of subcutaneous fat thickness prior to inoculation was performed.•With use of the above measures, sufficient antibodies dev...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of infectious diseases 2021-12, Vol.113, p.90-92
Hauptverfasser: Shinozuka, Jun, Hata, Michiaki, Eguchi, Hiromi, Mori, Masahiro, Eguchi, Mitsunori, Fukui, Mototaka, Sai, Natsuki, Imashuku, Shinsaku, Sueyoshi, Atsushi
Format: Artikel
Sprache:eng
Schlagworte:
COVID-19
COVID-19 Vaccines
effective utilization
Humans
low dead space syringe
Pfizer vaccine
SARS-CoV-2
Short Communication
Syringes
Vaccination
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•In maximally utilizing COVID vaccine, syringes with low dead space (LDS) are required.•We employed insulin LDS syringes, when no suitable syringes were procured.•US assessment of subcutaneous fat thickness prior to inoculation was performed.•With use of the above measures, sufficient antibodies developed in the recipients.
ISSN:1201-9712
1878-3511
DOI:10.1016/j.ijid.2021.09.068